Article
Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines.
Journal of immunology (Baltimore, Md. : 1950) - 15 May 2013
Chen Hsin-Wei, Chen Hsin-Yu, Wang Li-Tzu, Wang Fu-Hui, Fang Li-Wen, Lai Hsiu-Yu, Chen Hsuan-Hsu, Lu Jean, Hung Ming-Shiu, Cheng Yao, Chen Mei-Yu, Liu Shih-Jen, Chong Pele, Lee Oscar Kuang-Sheng, Hsu Shu-Ching
Abstract excerpt
Mesenchymal stem/stromal cells (MSCs) are promising potential candidates for the treatment of immunological diseases because of their immunosuppressive functions. However, the molecular mechanisms that mediate MSCs' immunosuppressive activity remain elusive. In this article, we report for the first time, to our knowledge, that secreted growth-regulated oncogene (GRO) chemokines, specifically GRO-γ, in human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
